TherapeuticsMD Inc is a biotechnology company focused on developing and commercializing innovative women's health products
The company aims to address unmet medical needs through its extensive portfolio of hormonal therapies and other innovative treatments designed specifically for women. By leveraging advanced scientific research and clinical development, TherapeuticsMD seeks to improve the quality of life for women experiencing various health conditions, including menopausal symptoms and reproductive health challenges. Their commitment to women's health is reflected in their ongoing efforts to bring new and effective therapies to market.
TherapeuticsMD (NASDAQTXMD) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday The Dow traded up 0.19% to 34,159.14 while the NASDAQ rose 0.84% to 13,631.99. The S&P 500 also rose, gaining, 0.30% to 4,379.06.
Gainers Benitec Biopharma (NASDAQBNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.
According to Benzinga Pro, during Q2, TherapeuticsMD (NASDAQTXMD) earned $112.28 million, a 329.05% increase from the preceding quarter. TherapeuticsMD also posted a total of $28.56 million in sales, a 47.73% increase since Q1.
Gainers Sunrise New Energy Co. Ltd. (NASDAQEPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New Energy effective as of August 10, 2022.
TherapeuticsMD (NASDAQTXMD) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Analysts estimate that TherapeuticsMD will report an earnings per share (EPS) of $-3.04.
